Ipro Tech | October 28, 2020
Ipro Tech and ARMA International announced today the results of its inaugural IG Maturity Index survey, seeking to gain evidence-based, quantifiable knowledge of how the information governance profession is advancing and how investments being made in IG policies, processes, and people are impacting organizations in terms of productivity and risk reduction. The result of the survey and accompanying research will be published annually, focusing on the critical areas for IG professionals to work on as they implement and improve their governance programs.
Samsara | September 13, 2021
Samsara, the pioneer of the Connected Operations Cloud, today announced it has been awarded a single-source multi-year contract to supply the State of Tennessee and participating government agency fleets with its Connected Operations Platform. As part of its ongoing commitment to innovation, the State of Tennessee will make Samsara's technology platform - spanning vehicle telematics, equipment monitoring, and driver safety - available to all state, municipal and county fleets. Collectively, these fleets serve the State of Tennessee's growing population of nearly seven million people.
Samsara is uniquely positioned to help public sector fleets elevate citizen services, save taxpayer dollars, and keep their employees safe. From public works agencies to sanitation teams to transit authorities, Samsara's Connected Operations Cloud empowers every department with the real-time data needed to harness actionable insights.
"In the world of government services, the efficient use of assets and resources is a top priority. With Samsara, these organizations gain visibility into operational data that can help them do just that - ultimately reducing maintenance costs, building fuel-efficient infrastructure, and streamlining response times to citizen complaints," Alexander Stevenson, vice president of product management at Samsara. "We're thrilled to have signed this agreement with the State of Tennessee and look forward to working together to make an impact on their local communities."
Utilizing the latest advancements in Internet of Things (IoT) connectivity, artificial intelligence, cloud computing and video imagery, Samsara is driving the digital transformation of physical operations. With Samsara's IoT sensors and Connected Operations Cloud, organizations can combine data from their fleets, equipment and work sites into one integrated platform. Public sector agencies can seamlessly access, analyze and act upon operational data across all departments to drive smarter decisions, increase efficiency and improve the day-to-day lives of both employees and community members.
With this agreement, the State of Tennessee joins more than 20,000 organizations using Samsara today to improve the efficiency, safety and sustainability of their operations.
Samsara is the pioneer of the Connected Operations Cloud, which allows businesses that depend on physical operations to harness IoT (Internet of Things) data to develop actionable business insights and improve their operations. Samsara operates in North America and Europe and serves more than 20,000 customers across a wide range of industries including transportation, wholesale and retail trade, construction, field services, logistics, utilities and energy, government, healthcare and education, manufacturing and food and beverage. Learn more about Samsara's mission to increase the efficiency, safety,
MilliporeSigma | December 30, 2021
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that it has been awarded a $136.7M USD contract award for the construction of a lateral flow membrane production facility over a three-year period at the company's Sheboygan, Wisconsin site. The contract award from the U.S. Department of Defense (DoD), on behalf of the U.S. Department of Health and Human Services, is part of an effort to ensure secure local supply and production capacity for critical products for pandemic preparedness.
"With this agreement, MilliporeSigma will construct a state-of-the-art lateral flow membrane production facility that will give our in vitro diagnostic (IVD) manufacturing customers greater flexibility and security of supply of our Hi-Flow™ Plus lateral flow membranes."
Matthias Heinzel, Member of the Executive Board and CEO, Life Science, Merck KGaA, Darmstadt, Germany
"Our lateral flow membranes have earned a reputation for high consistency among rapid diagnostic manufacturers and the already robust demand for this membrane has significantly increased since the onset of the pandemic. With this critical investment, we are expanding much-needed access to essential diagnostic testing as a trusted partner to the world's most sophisticated diagnostic manufacturers," said Jean-Charles Wirth, head of Applied Solutions, Life Science.
Building this new facility supports the overall Life Science business sector's strategy to add physical capacity and expand its regional network to enable further growth of its key portfolios.
Hi-Flow™ Plus Lateral flow membrane is used in rapid diagnostic test kit manufacturing by the Life Science business' customers, enabling reproducible results due to its consistent quality and optimized properties. The rapid test kits are used for a variety of applications, including Infectious Disease testing (Covid-19, HIV, Influenza, Malaria, etc.), as well as in women's health, biomarker detection, drug testing, food safety and animal health. Due to continuously increasing demand for lateral flow membrane, the Life Science business had already invested in a second membrane casting line in Cork, Ireland, which was recently completed, and expanded the range of other critical reagents (antibodies, beads, blockers, buffers) utilized to develop lateral flow rapid test kits. These strategic investments position the Life Science business as an important critical raw material supplier for the Diagnostic market, especially as the company prepares for IVD Regulation and Medical Device Regulation.
The Life Science business is undertaking an ambitious, multi-year program to increase production capacity and capabilities to support the growing global demand for lifesaving vaccines, therapies and diagnostics. Within the last year, the company has accelerated investments to expand capacity to produce its support Mobius® single-use assemblies in both the U.S. and France, as well as increased capacity for the production of cell culture media in the U.S. and UK, among others. Additionally, several expansion projects continue to advance across the company's manufacturing and distribution global network.
About the Life Science business of Merck KGaA, Darmstadt, Germany
The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has more than 23,000 employees and 59 manufacturing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics.